RAQUEL
PÉREZ ROBLES
Investigador en el periodo 2022-2023
Hospital Universitario San Cecilio
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (12)
2023
-
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate
Vaccines, Vol. 11, Núm. 11
-
Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 103-115
2022
-
Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab
Microchemical Journal, Vol. 182
-
Degradation and in-use stability study of five marketed therapeutic monoclonal antibodies by generic weak cation exchange liquid chromatographic method ((WCX)HPLC/DAD)
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1203
-
Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS
Analytical Methods, Vol. 14, Núm. 43, pp. 4359-4369
-
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers
Journal of Pharmaceutical and Biomedical Analysis, Vol. 221
2021
-
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies
Journal of Pharmaceutical and Biomedical Analysis, Vol. 203
2020
-
Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation
Scientific Reports, Vol. 10, Núm. 1
-
Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase
Journal of Pharmaceutical and Biomedical Analysis, Vol. 185
-
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes
Journal of Pharmaceutical Analysis, Vol. 10, Núm. 6, pp. 532-545
2019
2018
-
Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column
Journal of Pharmaceutical and Biomedical Analysis, Vol. 159, pp. 437-448